Short-term outcomes following treatment of recalcitrant cystoid macular edema secondary to radiation maculopathy using intravitreal brolucizumab

PURPOSE: To assess the efficacy of intravitreal brolucizumab (Beovu®, Novartis Pharmaceuticals) in a case of recalcitrant cystoid macular edema associated with radiation maculopathy secondary to retinoblastoma which was suboptimally responsive to other intravitreal anti-vascular endothelial growth f...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Ophthalmol Case Rep
Main Authors: Corradetti, Giulia, Corvi, Federico, Juhn, Alexander, Sadda, SriniVas R.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7595878/
https://ncbi.nlm.nih.gov/pubmed/33145457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2020.100981
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares